echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Sequoia and Qiming jointly invested, in vitro diagnostics cutting-edge completed 100 million yuan A round of financing

    Sequoia and Qiming jointly invested, in vitro diagnostics cutting-edge completed 100 million yuan A round of financing

    • Last Update: 2021-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Shenzhen World Life Technology Co.
    , Ltd.
    (hereinafter referred to as "World Life") announced that it has received 100 million yuan in Series A financing, led by Qiming Venture Capital, followed by Sequoia Capital China Fund
    .


    This round of financing will be used for the company to deepen the pipeline layout of blood coagulation diagnosis-related products, build a strong marketing team and enhance supply chain capabilities, so that Ward Life's innovative products can serve customers faster and better to benefit patients



    Blood coagulation detection is the routine direction of in vitro diagnosis.
    Many diseases may cause coagulation disorders, or the occurrence of trauma, pregnancy, cardiovascular, cerebrovascular, and blood diseases caused by coagulation dysfunction
    .


    Take the cardiovascular direction as an example: According to the statistics of the National Cardiovascular Center of China in 2019, the number of patients with cardiovascular disease in China is as high as 330 million.


    References: [1] Venus | Ward Life completed 100 million yuan in Series A financing, Qiming Ventures led the investment.
    Retrieved 2021-07-06, from https://mp.
    weixin.
    qq.
    com/s/HMtzUYJLD2_e7bbXdU0aIQ

    References: [1] Venus | Ward Life completed 100 million yuan in Series A financing, Qiming Ventures led the investment.
    Retrieved 2021-07-06, from https://mp.
    weixin.
    qq.
    com/s/HMtzUYJLD2_e7bbXdU0aIQ

    Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options
    .


    If you need guidance on treatment plans, please go to a regular hospital for treatment


    Note: This article aims to introduce the progress of medical and health research, not to recommend treatment options


    Copyright statement: This article is compiled and edited by WuXi AppTec's content team based on public information.
    Individuals are welcome to forward it to Moments.
    Media or institutions are not allowed to forward/copy to other platforms in any form without authorization
    .
    For forwarding authorization, please leave a message on the WeChat official account of "Chuangjianhui" to contact us
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.